Novartis has developed an AI-driven precision medicine platform, which uses machine learning to analyze patient data and identify the most effective treatment options for cancer patients.
The Platform
The platform will enable personalized treatment plans, taking into account individual patient characteristics and genetic profiles.
The platform has shown a 25% increase in treatment efficacy in clinical trials, offering new hope for cancer patients.